Combination chemotherapy followed by chemoradiation for stage III pancreatic adenocarcinoma (PA)

被引:0
|
作者
Cereda, S. [1 ]
Reni, M. [1 ]
Passoni, P. [1 ]
Rognone, A. [1 ]
Mazza, E. [1 ]
Nicoletti, R. [1 ]
Zerbi, A. [1 ]
Balzano, G. [1 ]
Di Carlo, V. [1 ]
Villa, E. [1 ]
机构
[1] Osped San Raffaele, Milan, Italy
关键词
D O I
10.1200/jco.2008.26.15_suppl.15667
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
15667
引用
收藏
页数:1
相关论文
共 50 条
  • [41] OUTCOMES OF NEOADJUVANT CHEMORADIATION WITH AND WITHOUT SYSTEMIC CHEMOTHERAPY IN RESECTABLE AND BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
    Trinh, Katherine V.
    Fischer, Dawn A.
    Gardner, Timothy B.
    Smith, Kerrington
    GASTROENTEROLOGY, 2019, 156 (06) : S324 - S325
  • [42] Multiagent Induction Chemotherapy Followed by Chemoradiation Is Associated With Improved Survival in Locally Advanced Pancreatic Cancer
    Torgeson, Anna
    Lloyd, Shane
    Boothe, Dustin
    Tao, Randa
    Whisenant, Jonathan
    Garrido-Laguna, Ignacio
    Cannon, George M.
    CANCER, 2017, 123 (19) : 3816 - 3824
  • [43] Racial disparities in the receipt of adjuvant chemotherapy in patients with resected stage I-III pancreatic adenocarcinoma.
    Sanford, Nina Niu
    Xu, Xiaohan
    Sher, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [44] Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma
    Sanford, Nina N.
    Aguilera, Todd A.
    Folkert, Michael R.
    Ahn, Chul
    Mahal, Brandon A.
    Zeh, Herbert
    Beg, Muhammad S.
    Mansour, John
    Sher, David J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (11): : 1292 - +
  • [45] Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy
    Hue, Jonathan J.
    Sugumar, Kavin
    Markt, Sarah C.
    Hardacre, Jeffrey M.
    Ammori, John B.
    Rothermel, Luke D.
    Winter, Jordan M.
    Ocuin, Lee M.
    SURGERY, 2021, 170 (01) : 207 - 214
  • [46] Final results of a phase III trial of gemcitabine (G) versus PEFG regimen in stage IVA or metastatic pancreatic adenocarcinoma (PA).
    Reni, M
    Cordio, S
    Passardi, A
    Panucci, MG
    Passoni, P
    Oliani, C
    Luppi, G
    Galli, L
    Nicoletti, R
    Villa, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 316S - 316S
  • [47] Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma
    Gerber, N.
    Ilson, D. H.
    Wu, A. J.
    Janjigian, Y. Y.
    Kelsen, D. P.
    Zheng, J.
    Zhang, Z.
    Bains, M. S.
    Rizk, N.
    Rusch, V. W.
    Goodman, K. A.
    DISEASES OF THE ESOPHAGUS, 2014, 27 (03) : 235 - 241
  • [48] Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma
    Chen, Emerson Y.
    Kardosh, Adel
    Nabavizadeh, Nima
    Foster, Bryan C.
    Mayo, Skye G.
    Billingsley, Kevin G.
    Gilbert, Erin W.
    Lanciault, Christian
    Grossberg, Aaron
    Bensch, Kenneth G.
    Maynard, Erin
    Anderson, Eric C.
    Sheppard, Brett C.
    Thomas, Charles R.
    Lopez, Charles D.
    Vaccaro, Gina M.
    CANCER MEDICINE, 2023, 12 (12): : 12986 - 12995
  • [49] Phase II study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma
    Chen, Emerson Yu-sheng
    Tormoen, Garth William
    Kardosh, Adel
    Nabavizadeh, Nima
    Foster, Bryan
    Mayo, Skye C.
    Billingsley, Kevin G.
    Gilbert, Erin W.
    Lanciault, Christian
    Grossberg, Aaron
    Bensch, Kenneth Gregory
    Maynard, Erin
    Anderson, Eric C.
    Sheppard, Brett C.
    Thomas, Charles R.
    Lopez, Charles D.
    Vaccaro, Gina M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [50] Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma
    Mizrak Kaya, Dilsa
    Nogueras Gonzalez, Graciela M.
    Harada, Kazuto
    Blum Murphy, Mariela A.
    Lee, Jeffrey H.
    Bhutani, Manoop S.
    Weston, Brian
    Thomas, Irene
    Rogers, Jane E.
    Das, Prajnan
    Badgwell, Brian D.
    Ajani, Jaffer A.
    ONCOLOGY, 2020, 98 (08) : 542 - 548